Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Arena Pharmaceuticals (ARNA) -- Ignore unavailable to you. Want to Upgrade?

To: Justinfo who wrote (2189)	2/10/2014 8:32:32 AM
From: The Ox	2 Recommendations Recommended By Justinfo wolfgangrene Respond to of 2274

Thanks. This morning's news: Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) reported that Eisai has secured improved patient access of BELVIQ® (lorcaserin HCl) with two leading healthcare benefit companies, and that the estimated number of insured commercial lives in the United States that have coverage for BELVIQ now exceeds 50 percent. CVS Caremark (NYSE: CVS) customers (employers and health plans) have broadened the coverage of BELVIQ, and eligible CVS Caremark members may have access to BELVIQ in either a preferred or non-preferred brand position depending on the design of the employer benefit or health plan. In addition, Aetna recently announced that it would offer BELVIQ as a preferred brand to eligible patients as part of its pilot program to self-insured plan sponsors nationwide. The Aetna (NYSE: AET) program, which offers access to lifestyle management programs and surgical options, will also measure improvements in health outcomes, productivity and medical costs.

To: Justinfo who wrote (2189)	2/13/2014 2:40:33 PM
From: The Ox	Read Replies (1) \| Respond to of 2274

FWIW, we hit my next target just now at 183.2 on the SPY Once again, this doesn't imply that this move is over, only that the odds are higher that a change in trend could occur here. One minor note, VXX has been flat (more or less) since 11am est....while the S+P has continued to rise. This divergence doesn't always imply much, as it may simply be that the near term futures players aren't being overly aggressive today. Intraday the VXX retested this morning's low, so a bounce trade might be worth a look, with a very tight stop placed if breaks under the low.....